GlassScriptPhysician profile
Herbert C Bazron
NPI 1609803048
$603.60
in general payments reported to CMS, 2019-2025
10 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.76 · 2020: $11.03 · 2022: $223 · 2023: $188 · 2024: $22.00 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $275.72 | 2022-2023 | Proclaim |
| Vertos Medical, INC. | $74.78 | 2022 | |
| Pfizer INC. | $71.04 | 2020-2023 | |
| Inspire Medical Systems, INC. | $38.81 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $28.76 | 2019 | |
| Lilly USA, LLC | $26.18 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $22.87 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $22.45 | 2025 | Evenity, Prolia |
| Dexcom, INC. | $22.00 | 2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $20.99 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Bazron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.